Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

OSMT

Osmotica Pharmaceuticals (OSMT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OSMT
DataOraFonteTitoloSimboloCompagnia
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/05/202322:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/03/202322:26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
27/01/202322:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
26/01/202323:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/08/202222:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/202221:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/202223:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/04/202223:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
30/03/202222:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202217:38GlobeNewswire Inc.UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202212:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
18/01/202212:50GlobeNewswire Inc.RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/01/202214:55GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
23/12/202112:15TipRanksH.C. Wainwright Thinks Osmotica Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OSMTOsmotica Pharmaceuticals PLC
20/12/202122:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
16/11/202123:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202122:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202112:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/11/202101:30GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/10/202122:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
13/10/202122:45GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/10/202123:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202115:04GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202106:31GlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/10/202122:26GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/09/202123:00GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OSMT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network